Marina Biotech Receives Milestone Payment From SMARTICLES Licensee MiNA Therapeutics
17 nov. 2015 08h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 17, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that it...
Marina Biotech Announces Third Quarter 2015 Financial Results
16 nov. 2015 17h00 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 16, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported financial...
Marina Biotech Reports That Licensee ProNAi Therapeutics Initiates 'Brighton' Phase II Trial of PNT2258 in Patients With Richter's Transformation
03 nov. 2015 08h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 3, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its...
Marina Biotech and Hongene Biotechnology Announce License Agreement
28 sept. 2015 08h30 HE
|
Marina Biotech, Inc.
SHANGHAI, CHINA and BOTHELL, WA--(Marketwired - Sep 28, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases and...
Marina Biotech Announces Second Quarter 2015 Financial Results
13 août 2015 17h00 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Aug 13, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
Marina Biotech Announces $1.1 MM Convertible Preferred Stock Financing
06 août 2015 08h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Aug 6, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...
Marina Biotech's CEQ508 Granted FDA Fast Track Designation for Familial Adenomatous Polyposis
05 août 2015 16h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Aug 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CEQ508, an...
Marina Biotech Expands European and Canadian Patent Protection of Its SMARTICLES Nucleic Acid Delivery Technology
10 juin 2015 08h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Jun 10, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the...
Marina Biotech Announces First Quarter 2015 Financial Results
14 mai 2015 16h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - May 14, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported...
Marina Biotech Announces SMARTICLES(R)-Mediated Delivery of a Double-Stranded Oligonucleotide to Immune Cells
05 mai 2015 08h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - May 5, 2015) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that its...